OrthoPediatrics Corp Net Income (Loss) Available to Common Stockholders, Diluted
OrthoPediatrics Corp (KIDS) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$39.65 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-03-04
- OrthoPediatrics Corp net income (loss) available to common stockholders, diluted for the quarter ending 2023-12-31 was -$6.69M.
- OrthoPediatrics Corp net income (loss) available to common stockholders, diluted for the quarter ending 2023-09-30 was -$4.59M, a 125.24% decline year-over-year.
- OrthoPediatrics Corp net income (loss) available to common stockholders, diluted for the quarter ending 2022-12-31 was -$7.70M, a 10790.28% decline year-over-year.
- OrthoPediatrics Corp net income (loss) available to common stockholders, diluted for the quarter ending 2022-09-30 was $18.19M.
- OrthoPediatrics Corp net income (loss) available to common stockholders, diluted for fiscal 2025 was -$39.65M.
- OrthoPediatrics Corp net income (loss) available to common stockholders, diluted for fiscal 2024 was -$37.82M.
- OrthoPediatrics Corp net income (loss) available to common stockholders, diluted for fiscal 2023 was -$20.97M, a 1798.30% decline from fiscal 2022.
- OrthoPediatrics Corp net income (loss) available to common stockholders, diluted for fiscal 2022 was $1.24M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$39.65M 10-K · filed 2026-03-04 | |||||
| 2024-12-31 | -$37.82M 10-K · filed 2026-03-04 | |||||
| 2023-12-31 | -$6.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$11.28M derived: sum of 2 quarters · filed 2026-03-04 | -$20.97M 10-K · filed 2026-03-04 | |||
| 2023-09-30 | -$4.59M 10-Q · filed 2023-11-07 | -$14.28M 10-Q · filed 2023-11-07 | ||||
| 2022-12-31 | -$7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $10.49M derived: sum of 2 quarters · filed 2025-03-05 | $1.24M 10-K · filed 2025-03-05 | |||
| 2022-09-30 | $18.19M 10-Q · filed 2023-11-07 | $8.93M 10-Q · filed 2023-11-07 | ||||
| 2021-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$2.13M derived: sum of 2 quarters · filed 2024-03-08 | -$16.26M 10-K · filed 2024-03-08 | |||
| 2021-09-30 | -$2.20M 10-Q · filed 2022-11-01 | -$16.33M 10-Q · filed 2022-11-01 | ||||
| 2020-12-31 | -$32.94M 10-K · filed 2023-03-01 | |||||
| 2018-06-30 | -$1.86M 10-Q · filed 2018-10-31 | -$2.69M 10-Q · filed 2018-08-09 | -$9.56M 10-Q · filed 2018-10-31 | -$7.69M 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | -$5.00M 10-Q · filed 2018-05-15 | |||||
| 2017-06-30 | -$3.02M 10-Q · filed 2018-10-31 | -$2.72M 10-Q · filed 2018-08-09 | -$8.45M 10-Q · filed 2018-10-31 | -$5.43M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | -$2.71M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |